RBC sets USD 24.00 target for Sotera Health stock

Published on 10/17/2026 at 18:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Year to date, gains reached 1.42 percent. Sotera Health stock closed at USD 17.89 on October 16, 2026, down 1.00 percent versus Nasdaq's USD 18.07 close.

Analyst view and reporting date

RBC Capital set a USD 24.00 target in a note dated October 5, 2026.
Sotera Health gained 1.42 percent year to date through October 16, 2026.
Sotera Health stock closed at USD 17.89 on October 16, 2026, down 1.00 percent versus the Nasdaq close of October 15, 2026.
The next earnings date is November 3, 2026.

SHC, US83601L1026, Illustration mit AI erstellt.

RBC Capital analyst Ryan Halsted maintained a Buy rating and set a USD 24.00 target for Sotera Health in a note dated October 5, 2026, as reported by Markets Insider. The target stands 34.15 percent above the Nasdaq price of USD 17.89. Sotera Health stock closed at USD 17.89 on October 16, 2026 at 4:00 p.m. EDT, down 1.00 percent versus the Nasdaq close of October 15, 2026 at USD 18.07.

Year to date gain reaches 1.42 percent

Sotera Health was up 1.42 percent year to date through October 16, 2026. That performance sits below the S&P 500's 11.89 percent gain over the same period, placing the stock's progress in a wider market context.

The company provides sterilization solutions, laboratory testing and advisory services through Sterigenics, Nordion and Nelson Labs, according to Sotera Health. The business serves medical device, pharmaceutical and other healthcare customers.

Stock sits 9.87 percent below high

The October 16 session ranged from USD 17.79 to USD 18.51, while volume reached 1,856,070 shares against an average of 2,407,871. The 52-week range spans USD 13.09 to USD 19.85, leaving the closing price 9.87 percent below the high and 36.67 percent above the low.

Valuation and November 3 results

Sotera Health had a market capitalization of USD 5.1 billion and a trailing P/E ratio of 31.25 on October 16, 2026. Yahoo Finance lists November 3, 2026 as the estimated next earnings date.

Comparison with peers

Sotera Health: minus 1.00 percent, P/E 31.25, market capitalization USD 5.1 billion
STERIS (NYSE, USD): minus 0.74 percent, P/E 27.22, market capitalization USD 21.7 billion
Charles River Laboratories (NYSE, USD): minus 1.99 percent, P/E minus 61.89, market capitalization USD 14.5 billion

Trading closes at USD 17.89

The Nasdaq close places Sotera Health below its October 16 high and above its 52-week low. Its USD 24.00 analyst target remains the key valuation marker for the next reporting date.